114 related articles for article (PubMed ID: 36152762)
21. Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.
Mei T; Huang X; Tang S; Liu M; Zhang W; Yu H
Lipids Health Dis; 2024 Mar; 23(1):74. PubMed ID: 38461262
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review.
Axley P; Ahmed Z; Ravi S; Singal AK
J Clin Transl Hepatol; 2018 Mar; 6(1):79-84. PubMed ID: 29607308
[TBL] [Abstract][Full Text] [Related]
23. Socio-economic factors associated with loss to follow-up among individuals with HCV: A Dutch nationwide cross-sectional study.
van Dijk M; Boyd A; Brakenhoff SM; Isfordink CJ; van Zoest RA; Verhagen MD; de Knegt RJ; Drenth JPH; van der Valk M;
Liver Int; 2024 Jan; 44(1):52-60. PubMed ID: 37718515
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C Virus Infection and Chemotherapy in Breast Cancer: A Retrospective Chart Analysis.
Ghosh S; Chen ML; Weinberg J; Fikre T; Ko NY
Oncologist; 2020 Oct; 25(10):845-852. PubMed ID: 32488966
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany.
Runge M; Krensel M; Westermann C; Bindl D; Nagels K; Augustin M; Nienhaus A
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31936470
[TBL] [Abstract][Full Text] [Related]
26. Personalized care approaches to hepatitis C therapy: recent advances and future directions.
Schiano Moriello N; Pinchera B; Gentile I
Expert Rev Anti Infect Ther; 2024 Apr; 22(4):139-151. PubMed ID: 38459735
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a comprehensive strategy for the detection and treatment of hepatitis C infection in a population attending addiction centers.
Corona-Mata D; Rivero-Juárez A; Camacho Á; Ruiz-Torres L; Ruiz-Cáceres I; de la Fuente Darder B; Cáceres-Anillo D; de Guía Castro-Granados M; Lizaur-Barbudo M; Victoria Cabrera-Gisbert M; Redondo-Écija J; Aparicio-Aparicio A; Manchado-López L; Cobos L; Pérez-Valero I; Rivero A
Front Public Health; 2023; 11():1092960. PubMed ID: 36817894
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report.
Morihisa Y; Chung H; Towatari S; Yamashita D; Inokuma T
World J Hepatol; 2024 Feb; 16(2):286-293. PubMed ID: 38495284
[TBL] [Abstract][Full Text] [Related]
29. DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.
Villani R; Facciorusso A; Bellanti F; Tamborra R; Piscazzi A; Landriscina M; Vendemiale G; Serviddio G
PLoS One; 2016; 11(12):e0167934. PubMed ID: 27997563
[TBL] [Abstract][Full Text] [Related]
30. The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries.
Hill AM; Nath S; Simmons B
J Virus Erad; 2017 Jul; 3(3):117-123. PubMed ID: 28758018
[TBL] [Abstract][Full Text] [Related]
31. Deficit Accumulation Index and Biological Markers of Aging in Survivors of Childhood Cancer.
Williams AM; Mandelblatt JS; Wang M; Dong Q; Armstrong GT; Bhakta N; Brinkman TM; Ehrhardt MJ; Mulrooney DA; Gilmore N; Robison LL; Yasui Y; Small BJ; Srivastava D; Hudson MM; Ness KK; Krull KR; Wang Z
JAMA Netw Open; 2023 Nov; 6(11):e2344015. PubMed ID: 37983031
[TBL] [Abstract][Full Text] [Related]
32. Update on hepatitis C: Direct-acting antivirals.
Seifert LL; Perumpail RB; Ahmed A
World J Hepatol; 2015 Dec; 7(28):2829-33. PubMed ID: 26668694
[TBL] [Abstract][Full Text] [Related]
33. Evaluating short-term and long-term liver fibrosis improvement in hepatitis C patients post-DAA treatment.
Wang Y; Ma X; Zou Y; Yue M; Zhang M; Yu R; Chen H; Huang P
J Biomed Res; 2024 Mar; ():1-10. PubMed ID: 38808546
[TBL] [Abstract][Full Text] [Related]
34. Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.
Nguyen DL; Hu KQ
N Am J Med Sci (Boston); 2014; 7(1):21-27. PubMed ID: 25580186
[TBL] [Abstract][Full Text] [Related]
35. An update on hepatitis C virus.
Klenerman P; Fitzmaurice K
Clin Med (Lond); 2015 Dec; 15 Suppl 6():s33-6. PubMed ID: 26634679
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Virus Infection and Vaccine Development.
Guo X; Zhong JY; Li JW
J Clin Exp Hepatol; 2018 Jun; 8(2):195-204. PubMed ID: 29892184
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs.
Durand M; Nagot N; Nhu QBT; Vizeneux A; Thuy LLT; Duong HT; Thanh BN; Rapoud D; Vallo R; Quillet C; Tran HT; Michel L; Tuyet TNT; Hai OKT; Hai VV; Feelemyer J; Vande Perre P; Des Jarlais D; Minh KP; Laureillard D; Molès JP
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289803
[TBL] [Abstract][Full Text] [Related]
38. Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic.
Cerbu B; Pantea S; Bratosin F; Vidican I; Turaiche M; Frent S; Borsi E; Marincu I
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34200570
[No Abstract] [Full Text] [Related]
39. Micro-elimination of chronic hepatitis C virus in mental health settings: A prospective multicentre pragmatic trial.
Gofton C; Bondezi K; Kotze B; McKee K; Yesudoss A; McCaughan G; George J
Drug Alcohol Rev; 2024 May; ():. PubMed ID: 38773898
[TBL] [Abstract][Full Text] [Related]
40. No Patient Left Behind: A Novel Paradigm to Fulfill Hepatitis C Virus Treatment for Rural Patients.
Gormley MA; Moschella P; Cordero-Romero S; Wampler WR; Allison M; Kitzmiller K; Estes L; Heo M; Litwin AH; Roth P
Open Forum Infect Dis; 2024 May; 11(5):ofae206. PubMed ID: 38737428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
